Plain-English translation of NCT07030348 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying whether fluid collected from the small intestine during an endoscopy can help detect pancreatic cancer early. The study compares fluid samples from people with pancreatic cancer to samples from people with other pancreatic conditions or no pancreatic disease, looking for biological markers that could signal cancer before it becomes advanced.
Pancreatic cancer is difficult to detect early, and most patients are diagnosed only when the disease is advanced—when treatment options are limited. This research aims to find a simple, non-invasive way to catch pancreatic cancer at an earlier stage, when treatment may be more effective.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would have duodenal fluid collected during an endoscopy you're already scheduled to have for other medical reasons—the researchers simply collect a sample while you're undergoing that routine procedure. There are no additional separate visits or procedures required. The study is comparing fluid samples from people with pancreatic cancer to those with other pancreatic conditions to identify markers that might help with early detection.
AI-generated summary from trial data · Jun 15, 2026 · Not medical advice
United States
South Korea
Sponsor
Do Hyun Park
Collaborators
The Cleveland Clinic, University of Colorado, Denver
Enrollment target
~263 participants
Started
January 2024
Primary completion
December 2026
Age range
19 Years and older
Last updated on clinicaltrials.gov in June 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
HyeJin Song, CRC
Do Hyun Park
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.